Effect of clearing stomach and strengthening spleen on serum neuropeptide Y and leptin in patients with simple obesity
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 2
Abstract
<b>Objective</b> To explore the effects of clearing the stomach and strengthening the spleen in the treatment of simple obesity on serum neuropeptide Y (NPY) and leptin from the perspective of spleen and stomach. <b>Methods</b> A retrospective study was conducted on 86 patients with simple obesity who admitted to Heilongjiang University of Chinese Medicine from January 2020 to January 2022. According to different treatment methods, they were divided into control group and observation group, 43 cases in each group. The control group was given exercise combined with dietary guidance intervention, and the observation group was given clearing stomach and strengthening spleen prescription on the basis of the control group. The clinical efficacy, Chinese medicine symptom score, body fat content, body mass index (BMI), waist circumference, serum NPY, leptin and blood lipid levels were compared between the two groups. <b>Results</b> The total effective rate of observation group was higher than that of control group (95.35% vs 69.77%, χ2=9.771, P=0.002). After treatment, the scores of epigastric distensions, nausea and vomiting, bitter, sticky mouth odor and poor stool in the observation group were lower than those in the control group (P＜0.05). The body fat content, BMI and waist circumference of observation group were lower than those of control group after treatment （P＜0.05）. After treatment, serum levels of NPY, leptin, triglyceride (TG), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) in observation group were lower than those in control group (P＜0.05), while high density lipoprotein cholesterol (HDL-C) in observation group was higher than that in control group (P＜0.05). <b>Conclusion</b> Clearing stomach and strengthening spleen has certain curative effect in the treatment of simple obesity, which can effectively reduce body weight, reduce abdominal circumference, relieve symptoms such as poor stool and abdominal distension, reduce serum NPY and leptin levels, and regulate blood lipid.
Authors and Affiliations
WANG Ye*, MA Jian, LI Qingwei, HOU Ruirui, FENG Bo
Keywords
Related Articles
- EP ID EP736528
- DOI 10. 13429/j.cnki.cjcr.2024.02.023
- Views 64
- Downloads 1
Relationship between gut microbiota and hepatocellular carcinoma through two-sample Mendelian randomization study
Objective To investigate the potential association between 221 types of gut microbiota and hepatocellular carcinoma (HCC) using a two-sample Mendelian randomization approach, providing insights for the prevention and tre...
Research progress and treatment status of non-ischemic cardiomyopathy
Cardiomyopathy is a heart disease clinically characterized by enlargement of the heart, arrhythmia and heart failure alone or simultaneously. Ischemic cardiomyopathy is usually caused by coronary atherosclerotic lesions,...
Risk factors associated with severe coronavirus disease 2019 in maintenance hemodialysis patients
<b>Objective</b> To analyze the risk factors of severe coronavirus disease 2019 (COVID-19) in maintenance hemodialysis patients, and provide reference for early risk identification of the patients. <b>Methods</b> The...
Correlation between cardiometabolic index and stroke in middle-aged and older adults
Objective To explore the relationship between cardiac metabolic index (CMI) and stroke in middle-aged and elderly individuals based on a large sample cohort study. Methods Data were obtained from the China Health and Ret...
Efficacy and immunomodulatory effect of anlotinib combined with GP regimen in the treatment of advanced non-small cell lung cancer
<b>Objective</b> To explore the clinical efficacy and immunomodulatory effects of anlotinib capsule combined with GP regimen in the treatment of advanced non-small cell lung cancer(NSCLC). <b>Methods</b> Forty patients w...